Table 3
The hazard ratios (95% CIs) for cardiovascular events in patients treated with EBID or EBID + insulin compared to those treated with insulin, after adjusting for covariates, for all patients, and separately for patients without the history of cardiovascular diseases and without renal diseases before index date and during follow-up

Adjusted for gender, ethnicity, age at the start of cohort, duration of diabetes, BMI, HbA1c, systolic and diastolic blood pressure on the index date, history of CV disease, any renal disease prior to index date or during follow-up, use of metformin (MET), sulphonylurea (SU), and CPMs or antihypertensive medications time.